Regentis Biomaterials Ltd. (RGNT)

NYSEAMERICAN: RGNT · Real-Time Price · USD

1.800

+0.020 (1.12%)

At close: Jul 30, 2026, 4:00 PM EDT

1.780

-0.020 (-1.11%)

After-hours: Jul 30, 2026, 8:00 PM EDT

Regentis Biomaterials Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.25	0.25	-0.10	-0.70	0	0
Debt / EBITDA Ratio	-	-	5.31	-	-	9.09
Debt / FCF Ratio	-	-	-	-	-	46.73
Net Debt / Equity Ratio	-1.30	-1.30	-0.11	-0.16	-0.12	-0.08
Net Debt / EBITDA Ratio	0.89	0.89	5.06	-3.76	-3.72	4.99
Net Debt / FCF Ratio	4.50	4.50	-7.36	-5.96	-3.48	25.62
Quick Ratio	2.57	2.57	0.04	0.11	0.48	1.01
Current Ratio	2.65	2.65	0.07	0.11	0.66	1.14
Return on Equity (ROE)	2162.92%	2162.92%	-57.11%	43.83%	19.96%	-131.95%
Return on Assets (ROA)	-172.05%	-172.05%	221.38%	-185.94%	-58.24%	29.68%
Return on Invested Capital (ROIC)	-226.90%	-226.90%	36.16%	813.05%	191.43%	-90.15%
Return on Capital Employed (ROCE)	1104.28%	1104.28%	-21.22%	105.20%	562.80%	566.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Buyback Yield / Dilution	-249.41%	0.00%	-226.64%	-6.97%	0.00%	0.00%
Total Shareholder Return	-249.41%	0.00%	-226.64%	-6.97%	0.00%	0.00%

SEC Filings: 10-K · 10-Q